The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Suppression of renin–angiotensin gene expression in the kidney by paricalcitol
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Levey, A. S., Coresh, J., Balk, E., Kausz, A. T., Levin, A., Steffes, M. W., Hogg, R. J., Perrone, R. D., Lau, J., & Eknoyan, G. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-2-200307150-00013 · Cited by 4,615
1,25-Dihydroxyvitamin D3 is a negative endocrine regulator of the renin-angiotensin system
Li, Y. C., Kong, J., Wei, M., Chen, Z.-F., Liu, S. Q., & Cao, L.-P. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0215219 · Cited by 1,625
Self-citationTGF-β signaling in vascular fibrosis
RUIZORTEGA, M., RODRIGUEZVITA, J., SANCHEZLOPEZ, E., CARVAJAL, G., & EGIDO, J. (2007) · Cardiovascular Research · doi:10.1016/j.cardiores.2007.02.008 · Cited by 492
Renin-Angiotensin-Aldosterone System and Progression of Renal Disease
Rüster, C., & Wolf, G. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006040356 · Cited by 463
Huang, Y., Wongamorntham, S., Kasting, J., McQuillan, D., Owens, R. T., Yu, L., Noble, N. A., & Border, W. (2006) · Kidney International · doi:10.1038/sj.ki.5000011 · Cited by 423
Antiproteinuric effect of oral paricalcitol in chronic kidney disease
Agarwal, R., Acharya, M., Tian, J., Hippensteel, R. L., Melnick, J. Z., Qiu, P., Williams, L., & Batlle, D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00755.x · Cited by 377
RESNICK, L. M., MÜLLER, F. B., & LARAGH, J. H. (1986) · Annals of Internal Medicine · doi:10.7326/0003-4819-105-5-649 · Cited by 373
Paricalcitol Attenuates Renal Interstitial Fibrosis in Obstructive Nephropathy
Tan, X., Li, Y., & Liu, Y. (2006) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006050520 · Cited by 280
Self-citationRodríguez-Iturbe, B., Quiroz, Y., Nava, M., Bonet, L., Chávez, M., Herrera-Acosta, J., Johnson, R. J., & Pons, H. A. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.0197.2001 · Cited by 261
Self-citationEffect of 1,25(OH)2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats
Schwarz, U., Amann, K., Orth, S. R., Simonaviciene, A., Wessels, S., & Ritz, E. (1998) · Kidney International · doi:10.1046/j.1523-1755.1998.00951.x · Cited by 249
Mycophenolate mofetil prevents salt-sensitive hypertension resulting from angiotensin II exposure
Rodríguez-Iturbe, B., Pons, H., Quiroz, Y., Gordon, K., Rincón, J., Chávez, M., Parra, G., Herrera-Acosta, J., Gómez-Garre, D., Largo, R., et al. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00737.x · Cited by 241
Self-citationRenal Interstitial Fluid Concentrations of Angiotensins I and II in Anesthetized Rats
Nishiyama, A., Seth, D. M., & Navar, L. G. (2002) · Hypertension · doi:10.1161/hy0102.100536 · Cited by 230
Paricalcitol Capsule for the Treatment of Secondary Hyperparathyroidism in Stages 3 and 4 CKD
Coyne, D., Acharya, M., Qiu, P., Abboud, H., Batlle, D., Rosansky, S., Fadem, S., Levine, B., Williams, L., Andress, D. L., et al. (2006) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2005.10.007 · Cited by 227
公正, 池., Monden, T., Kanoh, T., Tsujie, M., Izawa, H., Haba, A., Ohnishi, T., Sekimoto, M., Tomita, N., 均, 塩., et al. (1998) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215549804600314 · Cited by 211
Mizobuchi, M., Morrissey, J., Finch, J. L., Martin, D. R., Liapis, H., Akizawa, T., & Slatopolsky, E. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006091028 · Cited by 196
Add-On Anti–TGF-β Antibody to ACE Inhibitor Arrests Progressive Diabetic Nephropathy in the Rat
Benigni, A., Zoja, C., Corna, D., Zatelli, C., Conti, S., Campana, M., Gagliardini, E., Rottoli, D., Zanchi, C., Abbate, M., et al. (2003) · Journal of the American Society of Nephrology · doi:10.1097/01.asn.0000074238.61967.b7 · Cited by 176
Levin, A., & Li, Y. C. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00651.x · Cited by 173
Self-citationZhang, Z., Yuan, W., Sun, L., Szeto, F. L., Wong, K. E., Li, X., Kong, J., & Li, Y. C. (2007) · Kidney International · doi:10.1038/sj.ki.5002296 · Cited by 173
Self-citationQuiroz, Y., Pons, H., Gordon, K. L., Rincón, J., Chávez, M., Parra, G., Herrera-Acosta, J., Gómez-Garre, D., Largo, R., Egido, J., et al. (2001) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.2001.281.1.f38 · Cited by 167
Self-citationTubulointerstitial damage and progression of renal failure
Rodríguez‐Iturbe, B., Johnson, R. J., & Herrera-Acosta, J. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.09915.x · Cited by 149
Vaziri, N. D., Bai, Y., Ni, Z., Quiroz, Y., Pandian, R., & Rodríguez‐Iturbe, B. (2007) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.107.123638 · Cited by 145
Self-citationRodríguez‐Iturbe, B., Ferrebuz, A., Vanegas, V., Quiroz, Y., Mezzano, S. A., & Vaziri, N. D. (2005) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.088062 · Cited by 143
Self-citationNakagawa, T. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00495.2006 · Cited by 134
Pathological Expression of Renin and Angiotensin II in the Renal Tubule after Subtotal Nephrectomy
Gilbert, R. E., Wu, L. L., Kelly, D. J., Cox, A. J., Wilkinson‐Berka, J. L., Johnston, C. I., & Cooper, M. E. (1999) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65139-5 · Cited by 131
Liu, E., Morimoto, M., Kitajima, S., Koike, T., Yu, Y., Shiiki, H., Nagata, M., Watanabe, T., & Fan, J. (2007) · Journal of the American Society of Nephrology · doi:10.1681/asn.2006010075 · Cited by 121
Systemic cardiovascular disease in uremic rats induced by 1,25(OH)2D3
Haffner, D., Hocher, B., Müller, D. N., Simon, K., König, K., Richter, C.-M., Eggert, B., Schwarz, J., Godes, M., Nissel, R., et al. (2005) · Journal of Hypertension · doi:10.1097/01.hjh.0000166849.72721.1c · Cited by 120
Evolution of Renal Interstitial Inflammation and NF-κB Activation in Spontaneously Hypertensive Rats
Rodríguez‐Iturbe, B., Quiroz, Y., Ferrebuz, A., Parra, G., & Vaziri, N. D. (2004) · American Journal of Nephrology · doi:10.1159/000082313 · Cited by 117
Self-citationAlvarez, V., Quiroz, Y., Nava, M., Pons, H., & Rodríguez‐Iturbe, B. (2002) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00199.2002 · Cited by 115
Self-citationEffects of 1,25(OH)2D3 in experimental mesangial proliferative nephritis in rats
Panichi, V., MIGLIORI, M., Taccola, D., Filippi, C., Nisco, L. D., Giovannini, L., Palla, R., Tetta, C., & Camussi, G. (2001) · Kidney International · doi:10.1046/j.1523-1755.2001.00775.x · Cited by 114
Franco, M., Martínez-Morales, F., Quiroz, Y., Galicia-Cruz, O. G., Bautista, R., Johnson, R. J., & Rodríguez‐Iturbe, B. (2007) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00645.2006 · Cited by 107
Self-citationEarly treatment with cGMP phosphodiesterase inhibitor ameliorates progression of renal damage
Rodragguez-Iturbe, B., Ferrebuz, A., Vanegas, V., Quiroz, Y., Espinoza, F., Pons, H., & Vaziri, N. D. (2005) · Kidney International · doi:10.1111/j.1523-1755.2005.00669.x · Cited by 105
Self-citationQuiroz, Y., Ferrebuz, A., Romero, F., Vaziri, N. D., & Rodríguez‐Iturbe, B. (2007) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00500.2007 · Cited by 99
Self-citationGonçalves, A. R. R., Fujihara, C. K., Mattar, A. L., Malheiros, D. M. A. C., Noronha, I. L., Nucci, G. D., & Zatz, R. (2004) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00238.2003 · Cited by 92
Lind, L., Wengle, B., WIDE, L. E., & Ljunghall, S. (1989) · American Journal of Hypertension · doi:10.1093/ajh/2.1.20 · Cited by 90
Mechanism of vitamin D action and its regulation
Dusso, A., & Brown, A. (1998) · American Journal of Kidney Diseases · doi:10.1053/ajkd.1998.v32.pm9808140 · Cited by 89
Pathophysiological Mechanisms of Salt-Dependent Hypertension
Rodríguez‐Iturbe, B., Romero, F., & Johnson, R. J. (2007) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2007.05.025 · Cited by 88
Retarding the progression of renal disease
Brenner, B. M. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.t01-2-00052.x · Cited by 74
Cellular mechanism of renin release
Schweda, F., & Kurtz, A. (2004) · Acta Physiologica Scandinavica · doi:10.1111/j.1365-201x.2004.01309.x · Cited by 71
VITAMIN D IN HEALTH AND DISEASE: Vitamin D Treatment in Chronic Kidney Disease
Andress, D. L. (2005) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2005.18408.x · Cited by 65
Rodríguez‐Iturbe, B., Sindhu, R. K., Quiroz, Y., et al. (2005) · Antioxidants and Redox Signaling · doi:10.1089/ars.2005.7.1269 · Cited by 58
Self-citationInhibitory effect of 1α,25-dihydroxyvitamin D3 on the growth of the renal carcinoma cell line
Nagakura, K., Abe, E., Suda, T., Hayakawa, M., Nakamura, H., & Tazaki, H. (1986) · Kidney International · doi:10.1038/ki.1986.74 · Cited by 55
Differential Inhibition of Renin mRNA Expression by Paricalcitol and Calcitriol in C57/BL6 Mice
Fryer, R. M., Rakestraw, P. A., Nakane, M., Dixon, D. B., Banfor, P. N., Koch, K. A., Wu-Wong, J. R., & Reinhart, G. A. (2007) · Nephron Physiology · doi:10.1159/000104875 · Cited by 54
Slatopolsky, E., Cozzolino, M. G., Lü, Y., Finch, J. L., Dusso, A., Staniforth, M., Wein, Y., & Webster, J. B. (2003) · Kidney International · doi:10.1046/j.1523-1755.2003.00029.x · Cited by 52
Economic evaluation and end-stage renal disease: From basics to bedside
Manns, B., Taub, K. J., & Donaldson, C. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.8235 · Cited by 41
Cited by
de Zeeuw, D., Agarwal, R., Amdahl, M., Audhya, P., Coyne, D., Garimella, T., Parving, H.-H., Pritchett, Y., Remuzzi, G., Ritz, E., et al. (2010) · The Lancet · doi:10.1016/s0140-6736(10)61032-x · Cited by 695
Rapa, S. F., Di Iorio, B. R., Campiglia, P., Heidland, A., & Marzocco, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms21010263 · Cited by 519
Vitamin D status and arterial hypertension: a systematic review
Pilz, S., Tomaschitz, A., Ritz, E., & Pieber, T. R. (2009) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.135 · Cited by 406
Fibrosis in Chronic Kidney Disease: Pathogenesis and Consequences
Panizo, S., Martínez-Arias, L., Alonso-Montes, C., Cannata, P., Martín-Carro, B., Fernández-Martín, J. L., Naves-Díaz, M., Carrillo-López, N., & Cannata-Andía, J. B. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22010408 · Cited by 372
Vimaleswaran, K. S., Cavadino, A., Berry, D. J., Jorde, R., Dieffenbach, A. K., Lu, C., Alves, A. C., Heerspink, H. J. L., Tikkanen, E., Eriksson, J., et al. (2014) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(14)70113-5 · Cited by 370
Metadata
- Authors
- Freundlich, M., Quiroz, Y., Zhang, Z., Zhang, Y., Bravo, Y., Weisinger, J. R., Li, Y. C., & Rodriguez-Iturbe, B.
- Venue
- Kidney International
- Publisher
- Elsevier BV
- Published
- 2008-12
- Volume
- 74
- Issue
- 11
- Pages
- 1394-1402
- ISSN
- 0085-2538 (ISSN-L)
- OpenAlex
- W2024711123
- Cited by
- 263
- References
- 44
- FWCI
- 16.72
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.